Vaccine Innovation. Beyond Convention.🔒 SSL Verified
Live Data Status: |E-commerce & Retail
Welcome to the detailed analysis for vaxcyte.com. This domain is officially recognized as Homepage - Vaxcyte. According to their official web presence, their primary focus is: "Detailed SEO and authority metrics for vaxcyte.com. Vaxcyte currently holds an estimated domain authority score of 97/100 in the .COM namespace based on our global index mapping.".
Table of Contents
- Tech Stack
- WordPress
- Link Profile
- Internal Pages: 55Outbound Links: 0
- Localization
- en
6-Month Traffic Trend Estimate
M1
M2
M3
M4
M5
M6
Estimated Market Value
$13,888
Based on domain age, authority, and keyword relevance.
TLD Availability Risk
- vaxcyte.comTaken
- vaxcyte.netTaken
- vaxcyte.orgTaken
- vaxcyte.ioTaken
- vaxcyte.coTaken
- vaxcyte.aiTaken
Content Snippets from vaxcyte.com
"We are dedicated to eliminating bacterial infections such as invasive pneumococcal disease, Group A Strep and Shigella to protect every child born and every adult at risk across the globe."
"Despite current efforts, Streptococcus pneumoniae bacteria continues to cause significant global morbidity and mortality, particularly for young children and older adults. This underscores the importance of advancing our potentially best-in-class pneumococcal conjugate vaccines (PCVs), including VAX-31, a 31-valent PCV, and VAX-24, a 24-valent PCV, being studied for the prevention of invasive pneumococcal disease (IPD)."
"We strive to overcome the limitations of conventional, cell-based vaccine approaches using advanced chemistry and modern synthetic techniques – including our cell-free protein synthesis platform – to produce broad-spectrum vaccines that are uniquely capable of breaking down bacteria's complex defense mechanisms while preserving robust immunogenicity."
"Our PCV franchise, comprising VAX-31 and VAX-24, has the potential to improve upon existing pneumococcal vaccines, setting a new standard-of-care and raising the bar for immunogenicity. Our site-specific, carrier-sparing platform has the potential to deliver the broadest-spectrum PCVs that provide protection against both currently circulating and historically prevalent serotypes. Additional candidates in early-stage development target Group A Strep and Shigella."
Key Topics & Focus Areas for vaxcyte.com:
Pushing the Boundaries of What’s Possible
Re-Engineering How Vaccines are Made
Building a Pipeline of High-Fidelity and Broad-Spectrum Vaccines
Latest News
Careers: Built to Scale with Purpose
Investing in America
By comparing vaxcyte.com to other leading websites in its niche, marketers and researchers can identify key traffic sources and growth opportunities. Explore our related resources below to find websites similar to vaxcyte.com.
Frequently Asked Questions
Is vaxcyte.com a safe and secure website?
Yes, according to our latest analysis, we detected a valid SSL certificate ensuring a secure connection.
What is the authority score of vaxcyte.com?
As of July 22, 2026, vaxcyte.com holds an estimated domain authority score of 62/100 based on our VisitRank tracking algorithms.
What are the top alternatives to vaxcyte.com?
You can find the best alternatives and similar sites to vaxcyte.com in our explore section, which includes competitors in the E-commerce & Retail sector.
Data Sources & Methodology: DNS telemetry and routing records are resolved via live root servers. Market valuation estimates are computed algorithmically based on proprietary historical indexation multiples and standardized digital asset appraisal methodologies.
Common Misspellings & Typo Domains for vaxcyte.com:
vxacyte.comvacyte.comvaaxcyte.comvexcyte.comvaxcyta.comvqxcyte.comvsxcyte.com